O. Berzoy

Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia

I. Láng, M. Bronchud, L. Mattano, 2019, Annals of Hematology.

Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.

A. Bardia, Yeon-Hee Park, D. Yardley, 2023, The Lancet. Oncology.